BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8142996)

  • 1. Measuring utility values for QALYs: two methodological issues.
    Smith R; Dobson M
    Health Econ; 1993 Dec; 2(4):349-55. PubMed ID: 8142996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost utility analysis of treatment options for gallstone disease: methodological issues and results.
    Cook J; Richardson J; Street A
    Health Econ; 1994; 3(3):157-68. PubMed ID: 7921059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility analyses of drug therapies in breast cancer: a systematic review.
    Nerich V; Saing S; Gamper EM; Kemmler G; Daval F; Pivot X; Holzner B
    Breast Cancer Res Treat; 2016 Oct; 159(3):407-24. PubMed ID: 27572551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility in practice: a policy maker's guide to the state of the art.
    Gerard K
    Health Policy; 1992 Jul; 21(3):249-79. PubMed ID: 10120196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set.
    Kreimeier S; Greiner W
    Value Health; 2019 Jan; 22(1):31-37. PubMed ID: 30661631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments.
    Fryback DG; Lawrence WF
    Med Decis Making; 1997; 17(3):276-84. PubMed ID: 9219187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiropody and the QALY: a case study in assigning categories of disability and distress to patients.
    Bryan S; Parkin D; Donaldson C
    Health Policy; 1991 Jul; 18(2):169-85. PubMed ID: 10113685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framing and labelling effects in health descriptions: quality adjusted life years for treatment of breast cancer.
    Gerard K; Dobson M; Hall J
    J Clin Epidemiol; 1993 Jan; 46(1):77-84. PubMed ID: 8433117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QALY league tables: handle with care.
    Gerard K; Mooney G
    Health Econ; 1993 Apr; 2(1):59-64. PubMed ID: 8269048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility scores for vesicoureteral reflux and anti-reflux surgery.
    Nelson CP; Routh JC; Logvinenko T; Rosoklija I; Kokorowski PJ; Prosser LA; Schuster MA
    J Pediatr Urol; 2015 Aug; 11(4):177-82. PubMed ID: 25975732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-adjusted life years, utility theory, and healthy-years equivalents.
    Mehrez A; Gafni A
    Med Decis Making; 1989; 9(2):142-9. PubMed ID: 2501627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-adjusted life years: origins, measurements, applications, objections.
    Schwartz S; Richardson J; Glasziou PP
    Aust J Public Health; 1993 Sep; 17(3):272-8. PubMed ID: 8286504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative to QALYs: the saved young life equivalent (SAVE).
    Nord E
    BMJ; 1992 Oct; 305(6858):875-7. PubMed ID: 1301030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cost-utility analysis; uncertainties restrict applicability].
    de Neeling JN
    Ned Tijdschr Geneeskd; 2004 May; 148(22):1106-10. PubMed ID: 15198066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health.
    Gold MR; Stevenson D; Fryback DG
    Annu Rev Public Health; 2002; 23():115-34. PubMed ID: 11910057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing health utilities in schizophrenia. A feasibility study.
    Voruganti LN; Awad AG; Oyewumi LK; Cortese L; Zirul S; Dhawan R
    Pharmacoeconomics; 2000 Mar; 17(3):273-86. PubMed ID: 10947302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.